Trial intelligence / Profile preview

Lasix versus methyldopa for postpartum hypertension after magnesium sulfate in severe preeclampsia

IRCT20180114038349N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in hypertension (HTN) and preeclampsia comparing Methyldopa arm with Lasix arm (2 arms). Primary endpoints: Systolic blood pressure and Diastolic blood pressure. Started Aug 2017; status: completed.

02

Drugs

furosemidemethyldopa
03

Conditions

hypertension (HTN)preeclampsia

Beyond the preview

Go deeper on IRCT20180114038349N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180114038349N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call